David Ewing Duncan

The rise of biobanks around the world promised lots of cheap and plentiful human DNA for scientists to study. Here’s how that’s going.

Roswell Biotechnologies wants you to believe its new chip will revolutionize the detection of viruses, DNA, and more. But it still has to prove itself.

Corporate America is embracing mindfulness more than ever as the pandemic rages. But what do they mean by “mindfulness,” and does it work?

This could be a “hinge year” in history: the opportunity to grasp a new and improved future for ourselves, our children, and our planet—or not.

Will the frenzied rush to understand and treat SARS-CoV-2 bring longer lasting benefit to the world of scientific research and medicine?

Stanford bioengineer Drew Endy doesn’t mind bringing dragons to life. What really scares him are humans.

Leroy Hood, pioneer of systems biology, is trying to upend medicine with a service that tests everything about you.

Gene-editing pioneer Jennifer Doudna’s new book reveals her dreams and nightmares about what she has unleashed.

Juan Enriquez bets on the end of undruggable targets, the power of programmable cells, and a machine that cooks up biological material.